北美呼吸吸入器市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品类型 [雾化器、计量吸入器 (MDI) 和干粉吸入器]、技术（手动操作吸入器和数字操作吸入器）和疾病适应症（哮喘、慢性阻塞性肺病、肺动脉高压等）
No. of Pages: 148 | Report Code: BMIRE00028397 | Category: Life Sciences
No. of Pages: 148 | Report Code: BMIRE00028397 | Category: Life Sciences
吸入药物是哮喘和慢性阻塞性肺病患者的主要治疗方法，通过吸入器给药。患有哮喘和慢性阻塞性肺病的患者通常每天需要一个或多个吸入器以保持呼吸道健康。因此，医疗保健专业人员担心药物之间的转换，因为它可能会因依从性低和误用气雾剂输送设备类型而对疾病控制产生负面影响。随着医疗保健预算压力的增加以及现有吸入疗法专利的同时到期，该地区正在生产和供应多种仿制药替代产品。用于治疗哮喘的几种吸入剂包括通用制剂，例如沙丁胺醇、左沙丁胺醇、异丙托铵、布地奈德和氟替卡松/沙美特罗。通用吸入器与品牌吸入器具有生物等效性，并且对身体具有相同的效果。随着专利到期，非专利哮喘吸入器的数量持续增加。随着越来越多的仿制药进入市场，预计竞争将会加剧，从而导致药品成本下降。推出“已批准的仿制药”也可以降低成本。因此，仿制药吸入器和哮喘药物的日益普及正在提高用药依从性，从而推动北美呼吸吸入器市场的发展。
北美呼吸吸入器市场概览
北美呼吸吸入器市场分为美国、加拿大和墨西哥。 2021年，美国在北美呼吸吸入器市场中占据最大份额。呼吸系统疾病发病率的持续上升预计将推动该市场的增长。目前，哮喘和慢性阻塞性肺病（COPD）是美国的主要健康负担。哮喘是一种由于气道狭窄和阻塞引起的慢性炎症性疾病。慢性阻塞性肺病是由于肺部气流受阻，导致慢性炎症性肺部疾病。在美国，吸烟是慢性阻塞性肺病的主要原因。美国吸烟率的不断上升正在推动呼吸吸入器市场的发展。根据美国疾病控制与预防中心 (CDC) 的数据，2020 年，美国约 5.0% 的成年人被诊断患有慢性阻塞性肺病、肺气肿或慢性支气管炎。大约 2500 万人患有哮喘，1480 万人患有慢性阻塞性肺病。 2018 年，慢性阻塞性肺病是美国第四大死因。此外，2020 年出生的婴儿中约有十分之一是早产。因此，美国慢性呼吸系统疾病和早产的日益流行正在推动北美呼吸吸入器市场的发展。
北美国呼吸吸入器市场细分
北美呼吸吸入器市场根据产品类型、技术、疾病适应症和国家/地区进行细分。
根据产品类型，北美呼吸吸入器市场分为雾化器、定量吸入器 (MDI) 和干粉吸入器。 2022 年，干粉吸入器细分市场在北美呼吸吸入器市场中占据最大份额。
根据技术，北美呼吸吸入器市场分为手动操作吸入器和手动操作吸入器。数字操作的吸入器。 2022 年，手动操作吸入器细分市场在北美呼吸吸入器市场中占据较大份额。
根据疾病适应症，北美呼吸吸入器市场细分为哮喘、慢性阻塞性肺病、肺动脉高压等。 2022 年，哮喘细分市场在北美呼吸吸入器市场中占据最大份额。
根据国家/地区，北美呼吸吸入器市场分为美国、加拿大、和墨西哥。 2022 年，美国将主导北美呼吸吸入器市场。
阿斯利康公司 (AstraZeneca Plc;) Beximco 制药有限公司；勃林格殷格翰国际有限公司；西普拉有限公司；葛兰素史克公司；皇家飞利浦公司；欧姆龙公司； OPKO 健康公司； PARI 呼吸设备有限公司；和 Teva Pharmaceutical Industries Ltd 是北美呼吸吸入器市场的领先公司。
Strategic insights for North America Respiratory Inhalers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 12,747.47 Million |
| Market Size by 2028 | US$ 17,991.07 Million |
| Global CAGR (2022 - 2028) | 5.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Respiratory Inhalers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Respiratory Inhalers Market is valued at US$ 12,747.47 Million in 2022, it is projected to reach US$ 17,991.07 Million by 2028.
As per our report North America Respiratory Inhalers Market, the market size is valued at US$ 12,747.47 Million in 2022, projecting it to reach US$ 17,991.07 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.
The North America Respiratory Inhalers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Respiratory Inhalers Market report:
The North America Respiratory Inhalers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Respiratory Inhalers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Respiratory Inhalers Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Respiratory Inhalers Market
